BTIG Sticks to Their Buy Rating for Shoulder Innovations, Inc. (SI)
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Shoulder Innovations, Inc., with a price target of $23.00. The company’s shares closed yesterday at $14.27.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zimmerman covers the Healthcare sector, focusing on stocks such as Solventum Corporation, Organogenesis Holdings, and GE Healthcare Technologies Inc. According to TipRanks, Zimmerman has an average return of -0.2% and a 43.32% success rate on recommended stocks.
Shoulder Innovations, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $22.00.
Based on Shoulder Innovations, Inc.’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $11.76 million and a GAAP net loss of $8.73 million.
Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SI in relation to earlier this year. Last month, Jeffrey S. Points, the CFO of SI bought 2,000.00 shares for a total of $29,631.65.
Read More on SI:
